Biopharma Trends 2025: 3 Things to Know Right Now
The global business climate is ever-evolving, and 2025 looks like it may be particularly challenging. Nowhere is that more evident than in the biopharma space, which is contending with multiple factors including a new administration in the US, new regulatory requirements in the EU, supply chain issues, and an uncertain economy. Despite these obstacles, however,…...
Read MoreTop Stories
Science, AI, and Human Ingenuity Converge to
Today, we're witnessing an unprecedented convergence of...
The Paradigm Shift from Traditional Scientific
In the rapidly evolving biopharma landscape, the approach to...
Leveraging Social Media to Transform Medical
This whitepaper explores the role of social media in...
Filter
Strategic Publication Planning: Infographic for Medical Affairs
Here's a quick and easy-to-follow guide on for medical affairs teams on the what, how...
Plain Language Summary Development in Japan: Current State and Challenges
This page contains supplementary information to support a poster presented at the Virtual 17th Annual...
Artificial Intelligence Is Democratizing Research and There’s More to Come
Today AI technologies are employed to both create and consume research. Scientists across the world...
Counting on AI: The Right Time for Researchers and Pharma to Embrace Artificial Intelligence
The right AI–powered tools and techniques can make a significant difference in how research is...
Publication Planning Training for Regional Medical Affairs Team
How a global pharma company overcame challenges of integration with regional teams in terms of...
US FDA (Food And Drug Administration) Social Medial Usage Guidelines: Compliance for Pharma Companies
This poster presents results of an analysis of trends in adherence of pharmaceutical companies to...